Morgan Stanley Dynavax Technologies Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Morgan Stanley holds 3,076,850 shares of DVAX stock, worth $40.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,076,850

Previous 2,993,498 2.78%

Holding current value

$40.1 Million

Previous $33.6 Million 1.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $11.61 $837,687 - $967,716	83,352 Added 2.78%	3,076,850 $34.3 Million
Q2 2024 Oct 17, 2024	BUY	$10.73 - $12.58 $3.96 Million - $4.65 Million	369,275 Added 14.07%	2,993,498 $33.6 Million
Q2 2024 Aug 14, 2024	BUY	$10.73 - $12.58 $3.96 Million - $4.65 Million	369,275 Added 14.07%	2,993,498 $33.6 Million
Q1 2024 Oct 17, 2024	SELL	$11.7 - $14.98 $4.32 Million - $5.53 Million	-369,275 Reduced 12.34%	2,624,223 $32.6 Million
Q1 2024 Aug 16, 2024	BUY	$11.7 - $14.98 $1.42 Million - $1.81 Million	121,101 Added 4.84%	2,624,223 $32.6 Million
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $1.42 Million - $1.81 Million	121,101 Added 4.84%	2,624,223 $32.6 Million
Q4 2023 Aug 16, 2024	SELL	$13.09 - $14.98 $6.42 Million - $7.35 Million	-490,376 Reduced 16.38%	2,503,122 $35 Million
Q4 2023 Feb 13, 2024	BUY	$13.09 - $14.98 $6.03 Million - $6.9 Million	460,839 Added 22.56%	2,503,122 $35 Million
Q3 2023 Nov 15, 2023	SELL	$12.64 - $14.99 $479,182 - $568,270	-37,910 Reduced 1.82%	2,042,283 $30.2 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $247,402 - $330,790	-25,117 Reduced 1.19%	2,080,193 $26.9 Million
Q1 2023 May 15, 2023	BUY	$9.44 - $11.88 $609,748 - $767,352	64,592 Added 3.17%	2,105,310 $20.7 Million
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $6.46 Million - $8.35 Million	628,657 Added 44.52%	2,040,718 $21.7 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $718,951 - $1.26 Million	-72,402 Reduced 4.88%	1,412,061 $14.7 Million
Q2 2022 Oct 27, 2022	BUY	$7.45 - $12.83 $1.65 Million - $2.84 Million	221,078 Added 17.5%	1,484,463 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $1.65 Million - $2.84 Million	221,078 Added 17.5%	1,484,463 $18.7 Million
Q1 2022 Oct 27, 2022	SELL	$9.75 - $14.44 $2.16 Million - $3.19 Million	-221,078 Reduced 14.89%	1,263,385 $13.7 Million
Q1 2022 May 13, 2022	SELL	$9.75 - $14.44 $1.59 Million - $2.36 Million	-163,134 Reduced 11.44%	1,263,385 $13.7 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $5.89 Million - $9.36 Million	-447,027 Reduced 23.86%	1,426,519 $20.1 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $17.2 Million - $37.2 Million	1,873,546 New	1,873,546 $36 Million

Others Institutions Holding DVAX

# of Institutions

276

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.65B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account